Healthcare -
Biotechnology - NASDAQ - US
$ 1.8267
-4.86 %
$ 19.6 M
Market Cap
-1.71
P/E
MRKR - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities MRKR - Marker Therapeutics, Inc.
1.11 M
LAST VALUE
-85.50%
2 YEAR CAGR
-56.54%
5 YEAR CAGR
4.53%
10 YEAR CAGR